Korean Stock Flows

Hyundai pharm (KRX: 004310)

현대약품 KOSPI Biotech & Pharma 의약품 제조업
Close (Oct 16, 2026)
₩7,290
+2.97%
Market cap
₩0T ($0.2B)
52-week range
₩3,500 – ₩15,960
P/E (trailing) · P/B · Div yield
75.94 · 2.32 · 0.41%

Who is buying Hyundai pharm?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net bought ₩3.2bn ($2M) of Hyundai pharm, the 84th largest foreign net purchase among 832 KOSPI stocks. Institutions net bought ₩0.0bn ($0M) and retail investors net sold ₩3.4bn ($2M) over the same window. Foreigners were net buyers on 13 of the 20 sessions.

Foreign investors hold 2.08% of Hyundai pharm's listed shares (KRX ownership data as of Oct 16, 2026), up from 0.6% twenty sessions earlier and 1.43% a year ago.

The stock closed at ₩7,290 on Oct 16, 2026: -27.03% over 20 sessions, -14.44% year-to-date, +91.34% over one year. The 52-week range is ₩3,500 – ₩15,960.

At ₩7,290 the stock trades at 75.94× trailing earnings (KRX, last completed fiscal year); no analyst consensus is available for a forward P/E.

Hyundai pharm share price, last 60 trading days (KRW)
10,835 8,748 6,662 4,575 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+2.2bn +1.1bn -1.1bn -2.2bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩7,290 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-10-15 ₩7,080 +₩1.1bn +₩0.0bn ₩-1.0bn
2026-10-14 ₩7,580 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-10-13 ₩7,630 +₩0.6bn +₩0.0bn ₩-0.6bn
2026-10-12 ₩7,620 ₩-0.3bn +₩0.0bn +₩0.3bn
2026-10-08 ₩7,760 +₩1.5bn ₩-0.0bn ₩-1.5bn
2026-10-07 ₩8,170 ₩-1.2bn ₩-0.0bn +₩1.2bn
2026-10-06 ₩8,340 ₩-0.6bn +₩0.0bn +₩0.6bn
2026-10-02 ₩8,340 +₩0.2bn ₩0.0bn ₩-0.2bn
2026-10-01 ₩8,480 +₩0.5bn ₩0.0bn ₩-0.5bn
2026-09-30 ₩8,400 +₩0.8bn +₩0.0bn ₩-0.8bn
2026-09-29 ₩8,530 +₩0.3bn ₩0.0bn ₩-0.2bn
2026-09-28 ₩8,830 ₩-2.2bn ₩0.0bn +₩2.0bn
2026-09-23 ₩8,860 ₩-0.0bn ₩-0.0bn +₩0.0bn
2026-09-22 ₩8,950 +₩0.4bn ₩-0.0bn ₩-0.3bn
2026-09-21 ₩9,270 +₩1.9bn ₩0.0bn ₩-1.8bn
2026-09-18 ₩10,070 ₩-2.2bn ₩-0.0bn +₩2.3bn
2026-09-17 ₩10,500 ₩-0.2bn ₩0.0bn +₩0.0bn
2026-09-16 ₩9,970 +₩1.8bn ₩-0.0bn ₩-1.8bn
2026-09-15 ₩10,120 +₩0.4bn +₩0.0bn ₩-0.5bn
2026-09-14 ₩9,990 ₩-0.0bn ₩-0.0bn +₩0.1bn
2026-09-11 ₩9,820 ₩-0.5bn ₩-0.0bn +₩0.6bn
2026-09-10 ₩9,770 ₩-0.5bn +₩0.0bn +₩0.4bn
2026-09-09 ₩10,300 +₩0.2bn ₩-0.0bn ₩-0.1bn
2026-09-08 ₩10,440 +₩0.5bn +₩0.0bn ₩-0.6bn
2026-09-07 ₩8,420 ₩-0.3bn ₩-0.0bn +₩0.4bn
2026-09-04 ₩7,950 ₩-2.0bn ₩-0.0bn +₩1.9bn
2026-09-03 ₩7,680 ₩-1.2bn +₩0.0bn +₩1.2bn
2026-09-02 ₩7,570 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-09-01 ₩8,290 +₩1.5bn ₩0.0bn ₩-1.4bn
2026-08-31 ₩6,380 ₩-2.0bn ₩-0.0bn +₩1.8bn
2026-08-28 ₩6,160 +₩0.4bn +₩0.0bn ₩-0.4bn
2026-08-27 ₩6,010 ₩-0.0bn ₩0.0bn +₩0.1bn
2026-08-26 ₩6,070 +₩0.3bn ₩0.0bn ₩-0.3bn
2026-08-25 ₩5,940 +₩0.3bn ₩0.0bn ₩-0.3bn
2026-08-24 ₩5,900 ₩-0.4bn ₩0.0bn +₩0.4bn
2026-08-21 ₩5,850 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-08-20 ₩6,110 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-08-19 ₩6,010 +₩0.2bn +₩0.0bn ₩-0.2bn
2026-08-18 ₩6,130 ₩-0.2bn ₩-0.0bn +₩0.2bn
2026-08-14 ₩6,310 +₩0.2bn +₩0.0bn ₩-0.2bn
2026-08-13 ₩6,490 +₩0.5bn ₩0.0bn ₩-0.4bn
2026-08-12 ₩6,400 +₩0.4bn ₩-0.0bn ₩-0.4bn
2026-08-11 ₩6,400 ₩-0.6bn ₩0.0bn +₩0.6bn
2026-08-10 ₩6,360 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-07 ₩6,150 ₩-0.0bn ₩0.0bn +₩0.1bn
2026-08-06 ₩6,590 ₩-0.3bn ₩0.0bn +₩0.2bn
2026-08-05 ₩5,850 +₩0.1bn +₩0.1bn ₩-0.2bn
2026-08-04 ₩5,600 +₩0.9bn ₩0.0bn ₩-0.8bn
2026-08-03 ₩5,410 ₩-1.2bn +₩0.0bn +₩1.1bn
2026-07-31 ₩5,360 +₩1.4bn ₩-0.0bn ₩-1.4bn
2026-07-30 ₩5,070 ₩-0.7bn +₩0.0bn +₩0.7bn
2026-07-29 ₩4,910 +₩0.3bn +₩0.0bn ₩-0.3bn
2026-07-28 ₩5,290 +₩0.7bn +₩0.0bn ₩-0.7bn
2026-07-27 ₩5,770 ₩-0.5bn ₩-0.0bn +₩0.5bn
2026-07-24 ₩6,110 +₩0.1bn +₩0.0bn ₩-0.0bn
2026-07-23 ₩6,300 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-22 ₩6,510 ₩-0.3bn ₩-0.0bn +₩0.3bn
2026-07-21 ₩6,830 ₩-0.4bn +₩0.0bn +₩0.4bn
2026-07-20 ₩6,220 ₩-1.7bn +₩0.0bn +₩1.6bn
2026-07-16 ₩7,600 +₩0.2bn +₩0.0bn ₩-0.2bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩0.0bn +$0M +₩0.0bn ₩-0.1bn
5 days +₩1.8bn +$1M +₩0.0bn ₩-1.9bn
20 days +₩3.2bn +$2M +₩0.0bn ₩-3.4bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Hyundai pharm stock?

Over the last 5 sessions foreign investors net bought ₩1.8bn ($1M) of Hyundai pharm; over 60 sessions they net sold ₩1.4bn ($1M); since Jan 1, 2026 they net sold ₩3.5bn ($3M). Over 20 sessions the stock is the 84th largest foreign net purchase among 832 KOSPI stocks.

How much of Hyundai pharm do foreign investors own?

Foreign investors own 2.08% of Hyundai pharm's shares as of Oct 16, 2026, versus 1.43% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩0.0bn ($0M) and retail investors net sold ₩3.4bn ($2M) of Hyundai pharm. Retail investors have been supplying the shares that foreigners and institutions are buying.

Is Hyundai pharm listed on KOSPI or KOSDAQ?

Hyundai pharm (현대약품) trades on KOSPI under KRX code 004310 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩181bn ($134M) – ₩7bn ($5M) ₩6bn ($5M)
2024 ₩176bn ($131M) -2.80% ₩0bn ($0M) -₩1bn (-$0M)
2025 ₩192bn ($142M) +9.10% ₩4bn ($3M) ₩3bn ($2M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows